<unk> (Rebinyn) is a recombinant DNA-derived<unk>  Factor<unk>  concentrate that is FDA approved for the on-demand treatment and control of bleeding episodes and perioperative management of bleeding.   Common adverse reactions include itching and injection site reactions.
Coagulation factor IX, GlycoPEGylated 
Vitamin K
Rapid plasma reagent
Recombinant factor VIIa
Factor XIII concentrate
Thrombin human
Factor IX complex
Factor ix complex